Cetilistat vs Orforglipron

Cetilistat wins for spot-targeting fat absorption with no systemic exposure, low risk of central appetite/energy disturbance, and seamless stacking on top of more potent fat-loss compounds. It's also much more forgiving in terms of lean-mass preservation since it doesn't drive hypophagia.

Orforglipron wins for raw efficacy in weight loss, true central appetite and craving suppression, long-term sustainability of a consistent calorie deficit, and unmatched oral convenience in the GLP-1 class. It serves as the actual centerpiece of a cut stack when aggressive results are the goal.

Pick Cetilistat if:

• The protocol needs a mechanistically pure fat-blocker to layer on top of an existing cut stack, not an all-in-one.
• Damage control is needed around high-fat meals, cheat days, or contest prep off-plan events.
• The stack includes oral AAS or compounds where dietary fat management is critical for lipid profile control.
• There is a desire to avoid central appetite blunting and preserve workout drive/performance while cutting.
• A user history of poor GI tolerability with orlistat but desire for a similar effect.

Pick Orforglipron if:

• Protocol calls for maximal, sustained weight or fat loss as the primary end-point (especially >10% body weight).
• Injectables are off the table and a true oral GLP-1 agonist is the needed anchor.
• Appetite suppression, craving reduction, and forced caloric restriction are core strategy
• Stacking with GH secretagogues or oral-only protocols is a priority.
• Extended lifestyle change and long-term maintenance are required after an injectable GLP-1 run.